Diagnosing and Treating Women with IDA: What Every Clinician Needs to Know
Click the "View Activity" button to view this activity.View Activity
CME/CE is no longer available for this activity
• Describe the impact of undertreated iron deficiency (ID) and iron deficiency anemia (IDA) in women
• Discuss the relationship of heavy menstrual bleeding (HMB) to ID and IDA
• Introduce evidence-based screening practices for women at risk for ID and IDA
• Assess and develop optimal treatment options for IDA based on clinical severity, efficacy, routes of administration, and clinical appropriateness
Chair, Women's Health Research Collaborative (WHrC)
Immediate Past Chair, FIGO Menstrual Disorders Committee
Clinical Professor, Department of Obstetrics & Gynecology
David Geffen School of Medicine at UCLA
Los Angeles, CA
This activity will take approximately 15 minutes to complete. To receive credit, participants are required to complete the pretest, view the online activity and complete the posttest and evaluation. To receive credit, 80% must be achieved on the posttest. A certificate will be immediately available. There is no fee to participate in the activity or for the generation of the certificate.
For questions, contact Michelle Forcier at firstname.lastname@example.org.
The Academy for Continued Healthcare Learning is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
The Academy for Continued Healthcare Learning designates this enduring material for a maximum of 0.25 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.